Saturday, July 11, 2026

Drug profile · INN

ezetimibe + atorvastatin

ezetimibe + atorvastatin (ATOZET) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — ezetimibe + atorvastatin

Quick answer

ezetimibe + atorvastatin (ATOZET) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN ezetimibe + atorvastatin
Brand ATOZET

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin Phase 1 · Tillomed Laboratories · Healthy volunteers
  2. ROSUVASTATIN for CHRONIC INFLAMMATORY RHEUMATIC… Approved · George Institute for · CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis

Frequently asked questions

What is ezetimibe + atorvastatin?

ezetimibe + atorvastatin (ATOZET) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for ezetimibe + atorvastatin?

ATOZET is a marketed brand name for ezetimibe + atorvastatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.